华威医疗品牌怎么样 申请店铺

我要投票 华威医疗在运动服行业中的票数:563 更新时间:2026-01-24
华威医疗是哪个国家的品牌?「华威医疗」是 杭州华威医疗用品有限公司 旗下著名品牌。该品牌发源于浙江省杭州市,由创始人华 *在1993年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力华威医疗品牌出海!将品牌入驻外推网,定制华威医疗品牌推广信息,可以显著提高华威医疗产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

华威医疗怎么样

杭州华威医疗用品有限公司地处沪、杭、甬“金三角”的交汇点,景色秀丽的富春江畔,占地10万平方米,项目总投资8000万元,是国家食品药品监督管理局定点生产医疗器械的专业厂家。 

公司主要生产经营各种医用缝合针,医用缝合线,手术刀片,医用内窥镜,微创手术器械等系列产品。产品规格齐、品种全,广泛应用于普外科、整形外科、显微外科、五官科、肛肠科、妇科、骨科、泌尿科、胸科、脑科等手术领域。产品畅销全国20多省市并远销全球多个国家和地区,深受海内外客户的赞誉。华威生产经营有20多年的历史,全国拥有近1000家客户。 

二十多年的发展,华威拥有了更坚硬的平台,公司的产品在行业中得到了较高的评价。 拥有多项专利技术和自主知识产权,在国内产品中居优良地位。

公司非常注重科技人才的引进和新产品的开发。目前有各类专业技术人才80余人, 占职工总数的29%, 并聘请同行业专家及各专家院校校高级技术人员定期来指导和培训,解决有关技术问题。为加强技术开发力度,公司开设了市级研发中心,成立了新产品开发小组,负责新产品、新技术的研究、设计、开发、工艺标准和质量标准的制定。并拥有国外引进一系列生产检测设备,使企业更具现代化、规模化。公司的产品在十万级净化车间包装,通过不断完善公司内部管理,各项管理标准严格按照此质量管理体系的要求运行。


Hangzhou Huawei medical supplies Co., Ltd. is located at the intersection of "Golden Triangle" of Shanghai, Hangzhou and Ningbo, along the beautiful Fuchun River, covering an area of 100000 square meters, with a total investment of 80 million yuan. It is a professional manufacturer of medical devices designated by the State Food and drug administration. The company mainly produces and operates a variety of medical suture needle, medical suture, surgical blade, medical endoscope, minimally invasive surgical instruments and other products. The products are of various specifications and varieties, which are widely used in general surgery, plastic surgery, microsurgery, pentalogy, anorectal surgery, gynecology, orthopedics, Urology, chest, brain and other surgical fields. The products sell well in more than 20 provinces and cities and are exported to many countries and regions around the world, and are highly praised by customers at home and abroad. Huawei has a production and operation history of more than 20 years, with nearly 1000 customers nationwide. With more than 20 years of development, Huawei has a harder platform, and its products have been highly appraised in the industry. With a number of patented technologies and independent intellectual property rights, it occupies an excellent position in domestic products. The company attaches great importance to the introduction of scientific and technological talents and the development of new products. At present, there are more than 80 professional and technical talents, accounting for 29% of the total number of employees. Experts from the same industry and senior technical personnel from various expert colleges and universities are invited to guide and train regularly to solve relevant technical problems. In order to strengthen the technical development, the company has set up a municipal R & D center and a new product development team to be responsible for the research, design, development, process standards and quality standards of new products and technologies. And has a series of production and testing equipment imported from abroad, making the enterprise more modern and large-scale. The company's products are packaged in the 100000 level purification workshop. Through continuous improvement of the company's internal management, all management standards are strictly in accordance with the requirements of this quality management system.

本文链接: https://brand.waitui.com/93402bd1e.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前涨跌不一,Arm涨超2%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,Arm涨超2%,英伟达涨超1%,谷歌涨0.1%,微软涨0.06%;特斯拉跌0.17%,奈飞跌0.11%,亚马逊跌0.07%,苹果跌0.03%。

45分钟前

热门中概股美股盘前涨跌互现,阿里巴巴跌超1%

36氪获悉,热门中概股美股盘前涨跌互现,截至发稿,阿里巴巴、京东跌超1%,小鹏汽车跌近1%,网易跌0.48%,蔚来跌0.21%;百度涨超1%,拼多多涨0.75%,理想汽车涨0.42%,B站涨0.09%。

45分钟前

晶升股份:拟购买为准智能100%股份,交易作价8.57亿元

36氪获悉,晶升股份公告,公司拟通过发行股份及支付现金的方式购买本尚科技等10名交易对方持有的为准智能100%股份,同时募集配套资金。为准智能100%股份的交易作价为8.57亿元。本次交易构成关联交易和重大资产重组,但不构成重组上市。交易完成后,为准智能将成为上市公司控股子公司。

45分钟前

天合光能:将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”

36氪获悉,天合光能公告,公司拟缩减“年产35GW直拉单晶项目”的募集资金投资金额,不再实施二期15GW项目,并将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”。新项目预计2026年底建成并投入运营。公司表示,本次变更有利于提高募集资金使用效率,合理优化资源配置,巩固市场地位,不会对公司正常经营产生不利影响。该事项尚需提交公司股东会和债券持有人会议审议通过后方可实施。

45分钟前

宝洁第二财季净销售额222亿美元,同比增长1%

当地时间1月22日,宝洁公司发布2026财年第二季度(2025年10-12月)财报。财报显示,第二财季净销售额为222亿美元,同比增长1%;摊薄后每股净收益为1.78美元,同比下降5%。该公司维持2026财年总销售额同比增长1%至5%的指引区间,将2026财年摊薄后每股净收益增长指引从原先的3%-9%调整至1%-6%。(界面)

45分钟前

本页详细列出关于华威医疗的品牌信息,含品牌所属公司介绍,华威医疗所处行业的品牌地位及优势。
咨询